How can I cure breast cancer?
Breast cancer is treated in a variety of ways, including surgery, treatment, chemotherapy, endocrine treatment and target-oriented treatment. Surgery, as the main treatment for breast cancer, includes, inter alia, improved root management of breast cancer, breast protection, mastectomy + breast rehabilitation. In the treatment of breast cancer, depending on the actual condition of the patient, doctors tend to apply these treatments in a scientific and comprehensive manner in order to achieve optimal treatment. Breast cancer should be treated in a precise and comprehensive manner, using a combination of treatments, taking into account the biological behaviour of the oncology and the physical condition of the patient, in order to improve the efficacy and quality of life of the patient. Health general practitioners should actively talk to breast cancer patients, inform them about the basics of breast cancer and help them build positive emotions. Psychological support, through the establishment of a sound family and social support system, enables patients to experience family and social care, effectively alleviates their negative emotions, and facilitates their recovery and rehabilitation. Patients with physiological support for breast cancer may experience adverse physiological reactions during the treatment, including nausea, vomiting, pain, tidal fever, etc. Patients should maintain a calm mood and be actively involved in drug or physical interventions. Drug treatment is divided into chemical drug treatment, endocrine treatment (hormonal treatment) and target-oriented treatment, depending on the mechanism in which the drug works. Chemical drug treatment is abbreviated chemotherapy, which can be divided into assisted chemotherapy and new assisted chemotherapy, through the use of cytotoxic drugs for the whole body treatment of cancer cells. Auxiliary chemotherapy refers to post-operative whole-body chemotherapy, which aims at eliminating the micro-cooks that cannot be removed from the operation, reducing the recurrence of cancers and increasing the survival of patients. For lymph transferers with impregnated breast cancer. The application of post-operative complementary chemotherapy is also appropriate for those with high-risk re-emergence factors that are lymphoma. Newly assisted chemotherapy is the whole-body chemotherapy that is performed prior to the implementation of a partial treatment (e.g., surgery or leaching) with a view to reducing the tumor first through chemotherapy and then treating the tumor with the treatment of surgery or leaching. This applies to patients with larger swellings (>5cm), transfer of lymphoma lymphoma lymphoma, breast-protective wishes, but a large tumour size and breast size ratio. The chemotherapy for breast cancer is generally used to interfere with the reproduction of cancer cells by altering or inhibiting the biochemical metabolic process of the cancer cells, mainly in the circa and verviol. Drugs in the ring: Common drugs include polyhospitals, tectonics, and so forth, and common adverse effects include heart toxicity (the most severe of all), bone marrow inhibition, digestive tract response, etc. Violines: Common drugs include vixasol, Dositas, etc., and common adverse effects include bone marrow inhibition, allergies, skin reactions (red spots), gastrointestinal responses, etc. Other: Drugs commonly used in clinical practice include cyclophosphate, 5-fluorourea, oral drugs in Capitabin, etc. Endocrine treatment prevents the growth of cancer cells by removing or disrupting hormones. In comparison to chemotherapy, endocrine treatment has the advantage of being effective, less toxic, user-friendly, non-residential, and easily acceptable to patients, although it is slow, but it is of long duration and is particularly appropriate for hormonal receptor-positive breast cancer patients at all stages. Common drugs against estrogens include triphenylamine (also known as mosaine), Toremiphine, etc., which can reduce post-cancer re-emergence and transfer and reduce the incidence of side breast cancer. Clinically applicable to pre-menopausal and post-menopausal women, common side effects include tidal heat, nausea, vomiting, intravenous blood clot formation, eye by-effects, vagina drying or increased genus. Common drugs for aromatic enzymes inhibitors include tactiles, Anatractics, Icemetán, etc., which reduce female diols to the point of treatment for breast cancer. Clinically applicable to post-menopausal women, treatment is more effective than his mosaic, with common side effects such as osteoporosis, joint pain, etc. Other clinically commonly used endocrine drugs include yellow-release hormones like Goserrin and Light Prerin, estrogen-resilient fluoride groups, etc. Target-oriented treatment is the cure for the disruption of the growth of tumours through specific disturbances. It has a lower effect on normal cells than chemotherapy, and the patient is more tolerant in the treatment process and applies to her-positive breast cancer patients. The main drugs are tulips, patsies, t-DM1, Lapatini, Quatini, etc. Depending on the condition, they can be used in combination or sequence with chemotherapy for new aids, assistive and end-stage breast cancer treatment. In some cases, endocrine drugs are also used in combination. Surgery continues to be the preferred treatment for patients with breast cancer, with the taboo use of surgical treatment for patients with poor overall health, severe diseases in the main organs, infirmity in the elderly, etc. The choice of the procedure should be based on a comprehensive assessment of the breast cancer stage and the patient ‘ s health. The mammography operation is to remove tissues of 1-2 cm around and around the tumor. For those with early breast cancer and breast retention needs, it is generally applied to those with a maximum tumour of 3 cm in stage II and a suitable breast size and a good breast shape after surgery. The third stage (except for inflammatory breast cancer) can also be carefully considered if the new assisted chemotherapy period meets the breast retention criteria. The full mastectomy surgery has a full mammography range, including argon tail and thoracic large muscles. It applies to patients with in situ cancer, micro-cancer and old and infirmity who are unfit for root therapy. Roots and amplifications cover the entire breast, chest muscles, chest muscles, armpits and all lymph nodes. In addition to the above, the extension of root hysterectomy must be accompanied by the removal of the aneurysm inside the chest and the lymphoma knot surrounding it. It is now underused because of the size of the cut. The difference between improved root therapy and root therapy is whether or not to remove thoracic muscles and/or small chest muscles, which are preserved by the operation and have a better post-operative appearance, which is a common method of surgery. The short-term radiotherapy treatment is used in combination with surgery or chemotherapy to reduce the transfer and recurrence of tumours and to increase the survival rate of patients by means of local treatment of irradiated cancer cells. In some cases, palliative treatment may also be considered for patients with advanced breast cancer. Medical treatment in Chinese medicine can be used as an aid for breast cancer, helping to mitigate the side effects and adverse effects of de-mobilisation, chemotherapy, endocrine treatment, and regulating the immune function and physical condition of patients. According to Chinese doctors, the causes of breast cancer are internal injuries, conjunctivation, and a real-temporal deficit, the corresponding treatments being hepatolization, bruising, haemorrhaging and retrieving liver and kidneys. At present, the primary treatment for breast cancer in Chinese medicine is the use of Chinese soups, such as tamarind soup, violet oyster soup, curd soup, etc.
